On August 26, Revolution Medicines, Inc. fell 5.34% in regular trading, trading at $200.13 USD/share, with Turnover of $88.97 million.
Within the Biotechnology sector where Revolution Medicines, Inc. belongs, the overall sector showed weakness. Among individual stocks, Moderna, Inc. down 5.97%, Amgen down 0.36%, AbbVie down 1.23%, Gilead Sciences flat 0.0%, Natera up 1.15%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments